International pharmaceutical companies produce Kaletra at high costs. To produce it locally will allow Cuba to treat more COVID-19 patients in the island territory.
The Cuban pharmaceutic Company MedSol Laboratories develops antiretroviral Kaletra; this drug has been effectively used to treat COVID-19 infected patients.
MedSol research and development group, Novatec, is because of Kaletra's testing and production. According to Adalberto Izquierdo Castro, Novatec’s manager, the drug is in the development stage. So far, Cuban laboratories produced three pilot batches and carried out the physical-chemical analysis. "Tests on the Cuban version of this drug have shown satisfactory results" said Izquierdo to local news media.
As he explained, the last steps would be the collection of results, compare it with the leading product, and register it in the Island's Center for State Control of Drugs, Equipment, and Medical Devices. After the drug patenting, Cuba could start subsequent production with the required prime materials.
@Cuba con una industria farmacéutica deprimida por un #BloqueoQueMata, opta x alcanzar la soberanía para no depender de mercados controlados por los yankis en momentos q el control de los medicamentos ya esgrimen como un arma política@DeZurdaTeamhttps://t.co/dzKtPegfiH— @Altocomolapalmareal (@AlbertoGar0302) April 26, 2020